|
Preceptor Mini-Series 6: The Reason I Jump - An Interprofessional Mini-Series
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to educate both preceptors and students regarding their participation in experiential rotations in an Interprofessional setting. Each individual video episode is 8 - 14 minutes in length and builds upon the next. The series follows multiple health professional preceptors including nurses, pharmacists, physicians, speech-language-pathologists, occupational therapists, athlethic tr... |
|
|
Preceptor Mini-Series 5: Change of Heart - An Interprofessional Mini-Series
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to educate both preceptors and students regarding their participation in experiential rotations in an Interprofessional setting. Each individual video episode is 5-10 minutes in length and builds upon the next. The series follows multiple health professional preceptors including nurses, pharmacists, physicians, speech-language-pathologists, occupational therapists, and physical t... |
|
|
Preceptor Mini-Series 4: A Glimpse Into the Life of a Community Pharmacy Preceptor
(See movie trailer below detailed description).
This 6-episode Series follows a pharmacy student and preceptor from orientation to the midpoint of a community rotation. Each video episode is 5-8 minutes in length and builds upon the next. During the Series you will experience a combination of inappropriate and quality interactions between the student, the preceptor, patients, and technicians. At moments throughout each episode, two preceptor experts provide humorous interactions and sha... |
|
|
Preceptor Mini-Series 3: Residency Preceptor's Experience
(See movie trailer below detailed description).
This 6-episode Series follows a pharmacy resident and preceptor during a clinical rotation at a hospital. Each video episode is 5-8 minutes in length and builds upon the next. During the Series you will view interactions between the resident, preceptor, residency director, and health-care team as they progress through the clinical rotation. At moments throughout each episode, two preceptor experts provide humorous interactions and share ... |
|
|
Preceptor Mini-Series 2: Adventures of Interprofessional Precepting
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to provide educational pearls to preceptors who train students or residents on experiential rotations in an Interprofessional setting.
Each video episode is 5-8 minutes in length and builds upon the next. The series follows three health professional preceptors including a nurse, pharmacist, and physician as they precept their students in an ambulatory care setting. Through a... |
|
|
Preceptor Mini-Series 1: Preceptor Pharm Tools
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to provide educational pearls to preceptors who train pharmacy students or residents on experiential rotations. Each video episode is 5-8 minutes in length and builds upon the next. The series follows a young preceptor and two students through a 6 week clinical rotation at a hospital. The two students are polar opposites and present unique challenges to the preceptor. At moments ... |
|
@MondayNightIBD OnDemand: Addressing the Cases That Challenge Your Practice
Statement of Need
Gastroenterologists are trailblazers in health care social media, and #MondayNightIBD (#MNIBD) has harnessed that energy to establish gastroenterologists as not just social media influencers but as clinical practice influencers as well. #MNIBD is not just a weekly social media conversation - it is an international platform that is moving the field forward by crowdsourcing the expertise of leading inflammatory bowel disease (IBD) experts, community clinicians, and patients ... |
|
|
Improving the Quality of Care for Patients with Atopic Dermatitis: Integrating Measurement-Based Tools Into Your Clinical Practice
Statement of Need
Attitudes about atopic dermatitis are evolving with the emergence of new and effective treatments. With the average dermatologist having not enjoyed caring for patients with AD for decades, there is little to no consensus in current practice about validated tools to assess and monitor the severity of the diseases and no consistent use of diagnostic or assessment tools. This lack of knowledge and education leads to confusion, poor recognition, and absence of assessment of AD ... |
|
|
Navigating the New Psoriasis Guidelines: Implications for Clinical Practice
Statement of Need:
The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have recently released new joint guidelines that outline best practices for the management of psoriasis (PsO) with biologics, the need for awareness and attention to comorbidities, and guidelines for pediatric PsO treatment. Clinicians must ensure that they are aware of these guidelines and of strategies to incorporate them into clinical practice, including the integration of biologic ther... |
|
|
At-Risk Patients Hidden in Plain Sight: Real-World Strategies for Screening and Treating Hepatitis B Virus
Statement of Need
Chronic hepatitis B virus (HBV) remains a global epidemic, resulting in significant morbidity and mortality. In 2015, there were 257 million people worldwide infected with HBV. In 2016, only 10.5% were diagnosed, with only 16.7% receiving treatment, and without intervention, there are 19 million deaths anticipated by the end of 2020. These numbers are startling as they exist despite the availability of effective treatment, and this is in part due to lack of clinician knowl... |
|
|
A Deeper Dive into NASH Diagnosis and Treatment: An Augmented Reality Experience
Statement of Need
Obesity and diabetes are on the rise, leading to an increased prevalence of non-alcoholic fatty liver disease (NAFLD), which in some cases may progress to non-alcoholic steatohepatitis (NASH). NAFLD effects approximately 30% of the U.S. population, with NASH effecting about 5%. NASH comes with a significant risk of progression to advanced liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Disease models project that the number of individuals with end-stage live... |
|
|
What the Future Holds for NASH: An Augmented Reality Look into Disease Stating and Targeted Therapies
Statement of Need
Given the rising prevalence of non-alcoholic fatty liver disease (NAFLD) and the societal and economic burden of its aggressive subtype, non-alcoholic steatohepatitis (NASH), it is important that hepatologists and gastroenterologists are equipped with the latest tools to diagnose NASH. While there are currently no approved therapies for the treatment of NASH, several targeted therapies are being investigated in clinical trials, with high probability of being approved in the ... |
|
Opioid Overdose Risk and Prevention
This is a 5 minute online activity included in the READINESS Opioid Learning Center "library".
This activity provides important information on opioid overdose – risks involved, prevention strategies & tips, and more to help you better understand how to combat opioid overdose and be better prepared in the event of an opioid overdose.
READINESS develops and hosts custom opioid eLearning centers for health systems, pharmacies, and organizations to support opioid stewardship and education ... |
|
|
How to Use Narcan (naloxone) Nasal Spray
This is a 5 minute online activity included in the READINESS Opioid Learning Center "library".
This activity provides important information on Narcan (naloxone) nasal spray – how to administer the medication, proper technique, and more to help you better understand how to use Narcan (naloxone) nasal spray.
READINESS develops and hosts custom opioid eLearning centers for health systems, pharmacies, and organizations to support opioid stewardship and education initiatives. Offer your com... |
|
|
Support Your Community with an Opioid eLearning Center Hosted by READINESS
READINESS develops and hosts custom opioid eLearning centers for health systems, pharmacies, and organizations to support opioid stewardship and education initiatives. Offer your community an intuitive and accessible eLearning center to support opioid education and awareness.
|
|
|
Don’t Snooze on the Latest Evidence on Excessive Daytime Sleepiness in OSA and Narcolepsy: An Expert-Guided Tour of the Sleep 2019 Annual Meeting
Residual excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) and narcolepsy is a common, debilitating condition that compromises patients' overall health, wellness, and safety. The field of sleep medicine is rapidly evolving to address the unmet needs of EDS as novel treatment options become available.
In this CME Outfitters dynamic, interactive infographic, expert faculty discuss the impact of EDS on daily functioning, highlight the efficacy of current and nov... |
|
|
Zooming In on the Education and Empowerment of Patients in AMD Care
FDA-approved agents that target vascular endothelial growth factor (VEGF) constitute important elements of optimal management of AMD. Prior authorization (PA) requirements limit patient access to these therapies. Navigating the PA process can be frustrating for patients, and may result in treatment abandonment leading to suboptimal outcomes. Hence, there is a need for patients to become advocates of their treatment choice.
The final module of this CME Outfitters Snack series describes step ... |
|
|
Recent Clinical Trial Data on the Safety and Efficacy of Current and Emerging Therapies to Optimize Schizophrenia Management
Safe and effective treatments for schizophrenia are imperative to optimizing personalized therapy, which helps in reducing relapse and promoting functional recovery in patients with schizophrenia. Emerging data on reducing symptoms, maintaining effective therapy over long-term periods, and minimizing treatment-related metabolic side effects can guide clinicians in choosing the best therapies for their patients. In the final episode of the CMEOcast podcast series on schizophrenia, expert facult... |
|
|
Navigating Through the Latest Advances in Monoclonal Antibodies: Translating Evidence to the Care of Patients with Psoriasis
Recent years have seen an increase in the number of therapeutic monoclonal antibodies (mAbs) that are available to treat a variety of conditions caused by immune-mediated chronic inflammation such as psoriasis. Health care professionals are often presented with complex and conflicting information surrounding concepts of mAb production and immunogenicity; therefore, there is a significant need for education in this area, especially as distinguishing the relative clinical efficacy and safety pro... |
|
|
Minimizing the Burden of Prior Authorization in AMD Through Actionable Strategies and Improved Communication
The development of anti–vascular endothelial growth factor (VEGF) agents has revolutionized the treatment of age-related macular degeneration (AMD). Nevertheless, optimal management of AMD is impeded by challenges in access to FDA-approved therapies. Step therapy, a type of prior authorization (PA) instituted by the payer, mandates that more cost-effective therapies be used before more expensive alternatives, in a stepwise approach. However, applying this strategy to vision-threatening disea... |
|
|
Long-Acting Injectables for Schizophrenia: An Effective, Yet Often Underutilized Tool for Rapid Symptom Reduction and Restoration of Function
Schizophrenia is a serious and debilitating disorder that often poses a considerable challenge to clinicians. While long-acting injectables (LAIs) have emerged as a viable means to address patient nonadherence – often a component of schizophrenia management – clinicians often fail to implement the use of LAIs. Many times this is due to clinicians not being aware of updates such as the introduction of LAIs with increased dosing intervals, knowledge that is an important aspect of narrowing p... |
|
|
Keeping the Patient in the Center in AMD Care
Age-related macular degeneration (AMD) is the leading cause of legal blindness in adults over age 50, but the development of agents that target vascular endothelial growth factor (VEGF) has revolutionized its treatment. There are currently two FDA-approved agents (ranibizumab and aflibercept) and one off-label anti-VEGF agent (bevacizumab) being used to treat patients with AMD, and data from emerging anti-VEGF agents have also demonstrated efficacy in improving visual acuity. However, step the... |
|
|
Honing in on the Appeal Process to Improve Access to Anti-VEGF Therapy for Patients with AMD
Step therapy requirements have limited patient access to FDA-approved, anti–vascular endothelial growth factor (VEGF) agents for the treatment of AMD. Prior authorization requests for these therapies are commonly denied. Hence, it is important that clinicians be aware of the approaches to overcome these barriers and implement systematic and clinically supported appeals that ensure uninterrupted anti-VEGF therapy for patients with AMD.
In the third module of this CME Outfitters Snack seri... |
|
|
Biomarkers for Diagnosis and Prognosis of MS
It is an exciting period for the clinical management of multiple sclerosis (MS), with an expanding treatment landscape and recent approval of new disease-modifying therapies (DMTs) for both relapsing and progressive MS. The Consortium of Multiple Sclerosis Centers (CMSC) 2019 Annual Meeting, the largest MS meeting in North America, features the latest information on cutting-edge research findings, clinical advances in the diagnosis and management of MS, and emerging care issues, as well as new... |
|
|
Current and Emerging Therapies for Schizophrenia: How MOA Affects Clinical Outcomes
Clinical trial data that addresses the safety and efficacy of antipsychotics is continuously emerging, with a focus on optimizing the management of schizophrenia. These data include the identification of strategies with novel mechanisms of action (MOAs) to effectively resolve symptoms and promote recovery while minimizing metabolic effects.
The second episode of this schizophrenia CMEOcast podcast series explores the MOAs of current and emerging therapies for schizophrenia. Expert faculty ... |
|
|
Clinical Insights on Recent Advances in Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) is a leading, fatal, autosomal recessive disorder that affects approximately one in 10,000 live births. Nusinersen was approved as the first targeted therapy for SMA, and since its groundbreaking approval data has been published that demonstrates its efficacy for both infantile- and later-onset SMA populations. Additionally, recent guidelines were published that provide evidence-based recommendations for the diagnosis and management of SMA.
However, despite the... |
|
|
Pharmacy Technician Series: Cultural Competency With Transgender Patients
See webpage |
|
Spanish for Pharmacists
A comprehensive course for pharmacists and pharmacy technicians to learn basic Spanish language skills to improve their patient counseling and communication skills in a pharmacy. Spanish for Pharmacists provides education on pharmacy "one-liners", tips to communicate with Spanish speaking patients, alphabet, punctuation, general vocabulary, numbers, colors, and more! |
|
|
Cardinal Health: The Innovative Delivery Solutions Group | An Overview
This 15-minute (non-accredited / free) activity provides an overview of the various products, services, and career opportunities available with Cardinal Health Innovative Delivery Solutions. The cactivity contains information on pharmacy management, remote order entry, and telepharmacy. As well as insights right from the Talent Acquisition Manager at Cardinal Health IDS. |
|
|
340B Drug Pricing Discount Program | An Overview
This 7-minute (non-accredited) activity provides an overview of the 340B Drug Pricing Discount Program. It is a ten minute, need-to-know overview of this topic for pharmacy students, tech students, and professionals to gain a working knowledge of 340B - who developed the program, which health systems qualify for the program, and how it impacts patients. |
|
|
The Pharmacy Experience | A Comprehensive Overview of the Pharmacy Market
A ten-hour, 68 module course (non-accredited) serving as an introduction to the pharmacy market and perfect for pharmacy students, pharmacy tech students, professionals new to the pharmacy market, and practitioners. The Pharmacy Experience course explores critical need-to-know subjects, practice settings, roles in a pharmacy, services, and pharmacy technology. |
|
|
Identifying Victims of Human Trafficking in the Health Care Setting
Many health care providers in the United States practice with the thought that human trafficking, also referred to as modern day slavery, does not exist here in the United States. Rather, they believe that it is a problem relevant only to far off distant countries.
The truth is that this terrible crime is occurring right here in the United States, just as it is in faraway places. In the United States, roughly 88% of victims have had an interaction with a healthcare provider during their ca... |
|
|
Telemedicine in the Era of COVID-19: Mitigating Risk for People Living with Multiple Sclerosis
Target Audience
This activity is intended for neurology and primary care physicians, nurse practitioners, PAs, nurses, pharmacists, rehabilitation specialists, mental health professionals, and other members of the healthcare team essential to the care of patients living with MS.
Learning Objectives
Review the history of and current known facts related to COVID-19
Describe the risks of COVID-19 in people living with MS
Discuss opportunities for care and best practices for implementat... |
|
|
The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment
Target Audience
The target learning audience for this initiative is neurologists, nurses, nurse practitioners, PAs, pharmacists, and other members of the healthcare team essential to the diagnosis and management of patients with NMOSD.
Statement of Need/Program Overview
This activity reviews evidence-based recommendations, challenges, and advances in the diagnosis and treatment of NMO spectrum disorder.
Learning Objectives
Upon completion of this activity, participants should be... |
|
|
11-Night Portugal, Spain & France CME AWAY® Cruise
Lisbon, Portugal ● Porto (Leixoes), Portugal ● Bilbao, Spain ● Bordeaux, France ● Nantes, Loire Valley, France ● St. Peter Port, Channel Islands ● Southampton, England |
|
|
8-Night Rome & Amalfi Coast CME AWAY® Land Tour
Rome, Italy ● Montecassino, Italy ● Amalfi Coast, Italy ● Minori, Italy ● Sorrento, Italy ● Pompeii, Italy |
|
|
7-Night Costa Mujeres CME AWAY® Resort - Addiction and Family Medicine
Grand Palladium Costa Mujeres & TRS Coral, Costa Mujeres, Mexico |
|
|
Apixaban Steps Up to the Plate: The Use of Apixaban for Treatment of Venous Thromboemboli in Patients with Cancer
The incidence of venous thromboemboli (VTE) development in patients with cancer has been reported as much as four to seven-fold higher than that for non-cancer patients. Anticoagulation management remains challenging for these patients, due to the higher risk of recurrent VTE (despite anticoagulant therapy) and bleeding complications, compared to patients without cancer. This application-based continuing pharmacy education activity will provide a 'journal club format' discussion for pharmacist... |
|
|
Therapeutic Interchange: Factors to Consider and Examples in Practice
For many reasons, including drug shortages, therapeutic interchange can be necessary. Pharmacists have the knowledge to make these recommendations, but don't always have the authority to do it without prior approval. That could be changing, and you should be ready. This course offers a step by step approach through decision tree analysis to implement therapeutic interchange when appropriate. Don't miss your opportunity to collaborate with prescribers for the best patient outcomes when their fi... |
|
|
Managing the Therapeutic Interchange Process
Drug shortages sometimes require pharmacists to dispense a different drug from the one prescribed. This course will equip you as a pharmacy technician to support this practice, called therapeutic interchange, through consistent documentation and effective communication between the pharmacy and prescribers. |
|
|
Complaints: Turning a Negative Into a Positive
Patient complaints are inevitable, no matter how committed you are to excellent service. Although most feel this is a negative situation, it can actually be positive for your pharmacy. Join this course to learn how complaints can affect your business, explore steps to handle patient complaints effectively, and review best practices for documentation and staff training requirements. |
|
|
Managing Overweight and Obese Patients
Obesity is a serious health problem and a common diagnosis in the United States, affecting over 40% of adults and 20% of adolescents (12-19 years). Obesity-related conditions include heart disease, type 2 diabetes, osteoarthritis, hypertension, certain types of cancer, and dyslipidemia, among others. Patients with obesity have annual medical costs that are $1,429 greater than those of people with a non-obese body mass index (BMI).
As we learn more about obesity, there is an increasing inter... |
|
|
HIV Emerging Trends in Prevention & Treatment- Florida Board Approved
This issue reviews recommended ARVs and focuses on the initial management of HIV in treatment-naïve adults, according to guidelines provided by the Department of Health and Human Services (DHHS). In addition, recommendations for ART in pregnancy are summarized and an update is included on the use of ARVs for PrEP and post-exposure prophylaxis (PEP), according to guidelines provided by the CDC.
This accredited program is targeted to pharmacists . |
|
|
Revolutionizing T2T in RA: Future Paradigms with JAK Inhibitors
How can clinicians be assured they have the most up-to-date information for improving their patients’ outcomes in RA care? In this clinical commentary, leading infectious disease expert Kevin Winthrop, MD, MPH, and Rheumatology experts Philip Mease, MD, MACR, and William F.C. Rigby, MD, discuss the latest evidence, safety data, and potential roles with the available and emerging JAK inhibitors, as well as current treat-to-target RA paradigms.
Because the patient plays such a critical rol... |
|
|
Precision Medicine with Polypharmacy in Multiple Sclerosis: What does it mean in practice?
Target Audience
Neurologists, primary care physicians, advance practice clinicians, nursing professionals, pharmacists, and other healthcare professionals involved in the care of patients with MS.
Learning Objectives
Summarize approaches to providing personalized medicine for MS diagnosis and management while minimizing drug interactions with medications for common comorbidities
Appraise current data on biomarkers for differentiating MS from other disorders and MS phenotypes
Evaluat... |
|
|
Danube River Cruise on Crystal: Exploring Medicine, Dentistry & the European Healthcare Model
Danube River Cruise on Crystal
Exploring Medicine, Dentistry &
the European Healthcare Model
Budapest to Vilshofen on Crystal Ravel
September 19 – 26, 2021
Join PES for 7 nights & discover the heart of Old-World Europe, exploring timeless imperial cities and the plentiful UNESCO World Heritage Sites along the regal & romantic Danube River aboard the luxurious, 106-guest all-inclusive, all-suite, butler-serviced Crystal Ravel.
River Cruise Itinerary Highlights:
Overnight in Budapes... |
|
|
Deciphering Rare irAEs: A Go-to-Guide
This immersive CME infographic will provide a stepwise visual to support improved recognition and management of rare immune-related adverse events (irAEs) for patients on immune checkpoint inhibitors (ICPIs). The infographic will synthesize and visualize data, guidelines and decision-making recommendations, as well as imbed faculty commentaries that offer “how-to” methods for introducing strategies and practical resources that support personalized therapeutic management.
This activity i... |
|
|
10-Night Canadian Maritimes Coastal Wonders CME AWAY® Land Tour
Halifax, Nova Scotia | Peggy’s Cove | Mahone Bay | Lunenburg | Cape Breton Island | Baddeck | Cabot Trail | Prince Edward Island | Saint John, New Brunswick |
|
|
Kansas City Heart Rhythm Virtual Symposium 2020
The purpose of this virtual symposium is to update medical practitioners on the future of cardiac electrophysiology (EP), and on new diagnosis and treatment guidelines in the care and management of patients with arrhythmias, heart failure and other issues impacting the electrical system of the body. Participants will learn about advances in ablation techniques, device management, appropriate use criteria, and survey new developments in guidelines and recommendations. A review of clinical trial... |
|
|
Point of Care Testing: Assessment and Administration (Technician)
This course is designed to provide frontline pharmacy teams with information to assess patients’ need for point of care tests, determine the appropriate test to administer, and collect nasal and throat specimens to determine the presence of Strep A, influenza, or COVID-19. Additional resources accompany this course, including guidance for blood pressure measurement, reusable form templates for gathering and documenting patient information, and a printable guide summarizing symptoms, testing ... |
|